Literature DB >> 3954864

The influence of estrogen on nigrostriatal dopamine activity: behavioral and neurochemical evidence for both pre- and postsynaptic components.

J B Becker, M E Beer.   

Abstract

The results of 3 experiments examining the influence of estrogen on the nigrostriatal dopamine (DA) system are reported. In two experiments the influence of hormonal manipulations on amphetamine (AMPH)-induced rotational behavior was investigated using rats with unilateral 6-hydroxydopamine lesions of the substantia nigra. It was found that: (1) female rats in estrus make more rotations than ovariectomized (OVX) rats; and (2) estrogen treatment (5 micrograms estradiol benzoate, daily for 4 days) in OVX rats enhances AMPH-induced rotational behavior 4 h and 4 days after estrogen treatment. During the intervening period, at 24 h after cessation of estrogen treatment, control and hormone-treated animals did not differ. In a third experiment, the effect of estrogen treatment on the release of endogenous DA from striatal tissue slices in superfusion was examined. Estrogen enhanced AMPH-stimulated striatal DA release 4 h after the last treatment relative to OVX controls. However, 24 h and 4 days after estrogen treatment DA release had returned to control levels. It is suggested that estrogen has an immediate potentiating effect on striatal DA release, and this may be responsible for the increased behavioral response to AMPH 4 h after estrogen treatment. The previously demonstrated increase in postsynaptic striatal DA receptors may be responsible for the second increase in AMPH-induced rotational behavior, that occurs 4 days after estrogen treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954864     DOI: 10.1016/0166-4328(86)90044-6

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  28 in total

Review 1.  The role of ovarian hormones in preserving cognition in aging.

Authors:  Jeri S Janowsky
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

2.  Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

Review 3.  Neuroimmunology and neuroepigenetics in the establishment of sex differences in the brain.

Authors:  Margaret M McCarthy; Bridget M Nugent; Kathryn M Lenz
Journal:  Nat Rev Neurosci       Date:  2017-06-22       Impact factor: 34.870

Review 4.  Sex differences in drug abuse.

Authors:  Jill B Becker; Ming Hu
Journal:  Front Neuroendocrinol       Date:  2007-08-24       Impact factor: 8.606

Review 5.  Rapid effects of ovarian hormones in dorsal striatum and nucleus accumbens.

Authors:  Katie E Yoest; Jacqueline A Quigley; Jill B Becker
Journal:  Horm Behav       Date:  2018-04-22       Impact factor: 3.587

Review 6.  Emergence of sex differences in the development of substance use and abuse during adolescence.

Authors:  Cynthia Kuhn
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

7.  The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats.

Authors:  D C Roberts; S A Bennett; G J Vickers
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 8.  Sexual differentiation of motivation: a novel mechanism?

Authors:  Jill B Becker
Journal:  Horm Behav       Date:  2009-05       Impact factor: 3.587

9.  Gonadal steroids mediate the opposite changes in cocaine-induced locomotion across adolescence in male and female rats.

Authors:  Sarah L Parylak; Joseph M Caster; Q David Walker; Cynthia M Kuhn
Journal:  Pharmacol Biochem Behav       Date:  2008-01-16       Impact factor: 3.533

10.  Estradiol and song affect female zebra finch behavior independent of dopamine in the striatum.

Authors:  Lace A Svec; Keith J Lookingland; Juli Wade
Journal:  Physiol Behav       Date:  2009-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.